Herbs Nutriproducts Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 2.97 Cr
as on 12-12-2024
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -46.19%
(FY 2022)
- Profit -171.07%
(FY 2022)
- Ebitda -114.64%
(FY 2022)
- Net Worth -527.63%
(FY 2022)
- Total Assets 0.79%
(FY 2022)
About Herbs Nutriproducts
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Asha Khaitan, Sushil Khaitan, and Anmol Choubey serve as directors at the Company.
- CIN/LLPIN
U15132MH2015PTC267964
- Company No.
267964
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Herbs Nutriproducts Private Limited offer?
Herbs Nutriproducts Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Edible Oil & Allied Products, Coconut Oil, Popular Category, Mind Care, Vitamins & Supplements, Mineral Supplements, Specialty Supplements, Glucosamine.
Who are the key members and board of directors at Herbs Nutriproducts?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Khaitan  | Director | 01-Sep-2015 | Current |
| Anmol Choubey | Director | 28-May-2024 | Current |
| Asha Khaitan | Director | 25-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Herbs Nutriproducts.
Herbs Nutriproducts Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 46.19% decrease. The company also saw a substantial fall in profitability, with a 171.07% decrease in profit. The company's net worth observed a substantial decline by a decrease of 527.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Herbs Nutriproducts?
In 2023, Herbs Nutriproducts had a public holding of 89.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Herbs Nutriproducts?
Herbs Nutriproducts has a workforce of 43 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Herbs Nutriproducts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Herbs Nutriproducts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
